We recently traveled to Boston, Massachusetts, for a State of the Science Summit™ on Genitourinary Cancers. At the meeting, experts from Dana-Farber Cancer Institute discussed the latest updates in prostate cancer, including the role of radiation, the question of androgen deprivation therapy–associated cardiac complications, and novel imaging modalities being used in nonmetastatic hormone-sensitive disease.